Amgen Balance Sheet Health
Financial Health criteria checks 1/6
Amgen has a total shareholder equity of $6.2B and total debt of $64.6B, which brings its debt-to-equity ratio to 1036.8%. Its total assets and total liabilities are $97.2B and $90.9B respectively. Amgen's EBIT is $8.2B making its interest coverage ratio 2.8. It has cash and short-term investments of $10.9B.
Key information
1,036.8%
Debt to equity ratio
US$64.61b
Debt
Interest coverage ratio | 2.8x |
Cash | US$10.94b |
Equity | US$6.23b |
Total liabilities | US$90.92b |
Total assets | US$97.15b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: AMGN34's short term assets ($30.3B) exceed its short term liabilities ($18.4B).
Long Term Liabilities: AMGN34's short term assets ($30.3B) do not cover its long term liabilities ($72.5B).
Debt to Equity History and Analysis
Debt Level: AMGN34's net debt to equity ratio (861.2%) is considered high.
Reducing Debt: AMGN34's debt to equity ratio has increased from 271.4% to 1036.8% over the past 5 years.
Debt Coverage: AMGN34's debt is not well covered by operating cash flow (13.1%).
Interest Coverage: AMGN34's interest payments on its debt are not well covered by EBIT (2.8x coverage).